China’s ophthalmic laser market is projected to grow at a CAGR of about 4% through 2033, driven by advancements in laser technologies and rising eye disease prevalence. The recent approval of the ZEISS VISUMAX 800 femtosecond laser system is set to enhance surgical efficiency and outcomes, improving accessibility and demand for advanced ophthalmic care.
